Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

Mar 25 2020

• By Joseph Haas

Tech Transfer regular column feature image

Related Content

AlloVir Gains PRIME Status For Anti-Virus T-Cell Therapy

Feb 13 2020

Related Companies

AlloVir, Inc.

Baylor College of Medicine

Soligenix, Inc.

University of Hawaii

CEL-SCI Corporation

University of Georgia Research Foundation

Asklepios BioPharmaceutical, Inc.

University of North Carolina

Feng Biosciences, Inc.

Genprex, Inc.

University of Pittsburgh

Bridge Biotherapeutics, Inc.

EpiCept Corporation

Yissum Research Development Co. Ltd.

Hebrew University

Rockefeller University

ViiV Healthcare

RespireRx Pharmaceuticals Inc.

University of Wisconsin system

Denali Therapeutics Inc.

University of Texas MD Anderson Cancer Center

Johns Hopkins University

Anagram Therapeutics, Inc.

Cystic Fibrosis Foundation

Additional Topics

Deals Coronavirus COVID-19 Business Strategies Commercial BioPharmaceutical Tech Transfer Round-Up

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window